NPCE

NASDAQ open

NeuroPace

8.04 USD
▼-0.10-1.23%
盘后 12.85 0.00%
2026-11-20
市值
$273.89M
市盈率
—
EPS
-0.56
股息率
—
52 周区间
5.46 – 19.60
成交量
207.40K
Beta
1.93
目标价
12.33
52W 低 5.4652W 高 19.60
价格走势

公司简介

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programmin...